679 Hoes Lane, Busch Campus
Piscataway, NJ 08854-5627
Telephone: 732-235-5310; Fax: 732-235-5318
Aaron J. Shatkin, Director
The Center for Advanced Biotechnology and Medicine (CABM) is
administered jointly by Rutgers, The State University of New Jersey, and
the University of Medicine and Dentistry of New Jersey. It is designated
by the New Jersey Commission on Science and Technology as one of the
state's Advanced Technology Centers. In addition to the two universities
and the commission, the center's constituencies include the New Jersey
pharmaceutical and related biotechnology industries; the National
Institutes of Health; the National Science Foundation; and private
organizations that support science and technology, including the Howard
Hughes Medical Institute. The mission of CABM is the advancement of
knowledge in the life sciences for the improvement of human health. CABM
researchers use structural, molecular, and cellular biology techniques
to improve the understanding of fundamental life processes and to
discover new approaches to life-threatening diseases including HIV/AIDS,
influenza, and hepatitis as well as autism, neurodegenerative disorders
of children, and cancer. Interactions with clinical scientists translate
CABM laboratory findings to patient care. CABM faculty also train
undergraduate, graduate, and postdoctoral students for leadership
positions in science and technology. CABM serves the public interest by
enhancing economic development through corporate collaborations in
research and education, by technology transfers, and through consultations.
